Search

everythinglearnresearchcommunity

for

Search:↓

Beard hair follicles have more androgen receptors than non-balding scalp hair follicles.

Cells from balding scalps have more androgen receptors than cells from non-balding scalps.

Balding hair follicle cells are smaller, grow less well, and need more effort to culture than non-balding cells.

SFRP2 and PTGDS may be key factors in female hair loss.

The research suggests that SFRP2 and PTGDS proteins might be indicators of female pattern hair loss and could contribute to hair loss.

RU58841 significantly increases hair growth rate and initiates more hair cycles, but doesn't affect hair thickness, suggesting it could be a new treatment for baldness.

Hair from balding and non-balding areas regrows similarly on mice.

Human hair growth is influenced by androgen hormones, and red deer mane follicles have similar hormone receptors.

A substance called DKK-1 increases in balding areas and causes hair cells to die when exposed to DHT.

Balding hair follicles have reduced growth factors and increased inhibitory factors, suggesting new treatment paths for hair loss.

Proteins like aPKC and PDGF-AA, substances like adenosine and ATP, and adipose-derived stem cells all play important roles in hair growth and health, and could potentially be used to treat hair loss and skin conditions.

Human scalp hair follicles have PGE2 and its receptors, which might affect hair growth.

Altered DHEA metabolism in hair follicles may be linked to hair loss in balding men.

Alopecia areata affects hair follicle structure, even in non-balding areas.

Protease Nexin-1 is found in human hair growth cells and is affected by male hormones.

Balding scalps show different gene expressions affecting hair growth compared to non-balding scalps.

Beard cells, unlike scalp cells, produce growth factors in response to testosterone, which may explain differences in hair growth.

A substance called prostaglandin D2 is found more in bald scalps and it stops hair from growing. Blocking its receptor could potentially treat hair loss.

Male pattern baldness is linked to higher levels of a certain receptor in the scalp, which leads to the shrinking of blood vessels and hair loss. Early treatment targeting this receptor could be more effective.

Certain proteins are found at higher levels in balding areas compared to non-balding areas, suggesting a link to hair loss. This could be useful for diagnosing and treating hair loss.

A new topical treatment may prevent hair loss from cancer therapy by adjusting cell death processes in hair follicles.

New genes found linked to balding, may help develop future treatments.

The study found genetic differences related to hair development that may explain hair loss in a patient with Trichorhinophalangeal syndrome type I.

High levels of testosterone and 5α-DHT can lead to cell death in cells important for hair growth.

Increased cell death and reduced cell growth in hair follicles contribute to baldness.

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

Dexamethasone may influence hair growth by altering estrogen receptor activity in hair cells.

Male pattern baldness involves hormone-related hair thinning, shorter hair, and inflammation.

Researchers developed a new device that improves non-incision hair transplant efficiency.